Authors: Fredriksson, I Liljegren, G Arnesson, LG Emdin, SO Palm-Sjovall, M Fornander, T Frisell, J Holmberg, L

Citation: I. Fredriksson et al., Time trends in the results of breast conservation in 4694 women, EUR J CANC, 37(12), 2001, pp. 1537-1544

Authors: Lind, PARM Wennberg, B Gagliardi, G Fornander, T

Citation: Parm. Lind et al., Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose, BREAST CANC, 68(3), 2001, pp. 199-210

Authors: He, Q Zou, L Zhang, PA Liu, JX Skog, S Fornander, T

Citation: Q. He et al., The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody, INT J B MAR, 15(2), 2000, pp. 139-146

Authors: Nystedt, M Berglund, G Bolund, C Brandberg, Y Fornander, T Rutqvist, LE

Citation: M. Nystedt et al., Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer - Self-rated physiological effects and symptoms, ACTA ONCOL, 39(8), 2000, pp. 959-968

Authors: Billgren, AM Rutqvist, LE Tani, E Wilking, N Fornander, T Skoog, L

Citation: Am. Billgren et al., Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival, ACTA ONCOL, 38(5), 1999, pp. 597-601

Authors: Lind, PARM Rosfors, S Wennberg, B Glas, U Bevegard, S Fornander, T

Citation: Parm. Lind et al., Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning, RADIOTH ONC, 49(3), 1998, pp. 245-254